Assyro AI

FDA Orange Book · active-ingredient family

Norfloxacin

Norfloxacin is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:NOROXIN · NDA 019384

2

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution/drops, tablet

ProductApplicantApplicationTEApproved
NOROXINRLDMERCKNDA 019384Oct 31, 1986
CHIBROXINMERCKNDA 019757Jun 17, 1991

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Norfloxacin — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.